These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11843466)

  • 21. VErapamil plus antiarrhythmic drugs reduce atrial fibrillation recurrences after an electrical cardioversion (VEPARAF Study).
    De Simone A; De Pasquale M; De Matteis C; Canciello M; Manzo M; Sabino L; Alfano F; Di Mauro M; Campana A; De Fabrizio G; Vitale DF; Turco P; Stabile G
    Eur Heart J; 2003 Aug; 24(15):1425-9. PubMed ID: 12909071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contemporary approach to electrical and pharmacological cardioversion of atrial fibrillation.
    Rajagopalan B; Curtis AB
    Postgrad Med; 2012 Nov; 124(6):26-35. PubMed ID: 23322136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug choices in the treatment of atrial fibrillation.
    Reiffel JA
    Am J Cardiol; 2000 May; 85(10A):12D-19D. PubMed ID: 10822036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of a bidirectional cavo-tricuspid isthmus block in persistent atrial fibrillation.
    Kim JB; Choi S; Joung B; Lee MH; Kim SS
    Yonsei Med J; 2012 Jan; 53(1):76-82. PubMed ID: 22187235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of hybrid therapy in the form of right atrial ablation and adjunctive therapy in refractory atrial fibrillation in symptomatic patients.
    Chakravarty S; Chatterjee S
    Am J Ther; 2012 Jan; 19(1):e18-20. PubMed ID: 20720486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catheter ablation of persistent atrial fibrillation : Beneficial effect of a short-term adjunctive amiodarone therapy on the long-term outcome.
    Kettering K; Gramley F
    Herzschrittmacherther Elektrophysiol; 2018 Mar; 29(1):133-140. PubMed ID: 28447159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catheter ablation of atrial flutter due to amiodarone therapy for paroxysmal atrial fibrillation.
    Reithmann C; Hoffmann E; Spitzlberger G; Dorwarth U; Gerth A; Remp T; Steinbeck G
    Eur Heart J; 2000 Apr; 21(7):565-72. PubMed ID: 10775011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hybrid therapy in the management of atrial fibrillation.
    Starek Z; Lehar F; Jez J; Wolf J; Novák M
    Curr Cardiol Rev; 2015; 11(2):167-79. PubMed ID: 25028165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term efficacy of hybrid pharmacologic and ablation therapy in patients with pilsicainide-induced atrial flutter.
    Hirao K; Okishige K; Yamamoto N; Otomo K; Azegami K; Isobe M
    Clin Cardiol; 2005 Jul; 28(7):338-42. PubMed ID: 16075827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Some recent randomized clinical trials in the management of atrial fibrillation.
    Wyse DG
    J Interv Card Electrophysiol; 2003 Oct; 9(2):223-8. PubMed ID: 14574035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of restoration of sinus rhythm by extensive antiarrhythmic drugs in predicting results of catheter ablation of persistent atrial fibrillation.
    Igarashi M; Tada H; Sekiguchi Y; Yamasaki H; Arimoto T; Kuroki K; Machino T; Murakoshi N; Aonuma K
    Am J Cardiol; 2010 Jul; 106(1):62-8. PubMed ID: 20609649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of "hybrid therapy" on long-term rhythm control and arrhythmia related hospitalizations in patients with drug-refractory persistent and permanent atrial fibrillation.
    Rao BH; Saksena S
    J Interv Card Electrophysiol; 2007 Mar; 18(2):127-36. PubMed ID: 17372812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiarrhythmic agents in facilitating electrical cardioversion of atrial fibrillation and promoting maintenance of sinus rhythm.
    Marcus GM; Sung RJ
    Cardiology; 2001; 95(1):1-8. PubMed ID: 11385184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrial fibrillation: what are the effects of drug therapy on the effectiveness and complications of electrical cardioversion?
    Sarubbi B; Ducceschi V; D'Andrea A; Liccardo B; Santangelo L; Iacono A
    Can J Cardiol; 1998 Oct; 14(10):1267-73. PubMed ID: 9852940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Can atrial fibrillation be managed without anti-arrhythmia drugs?].
    Blanc JJ; Mansourati J
    Arch Mal Coeur Vaiss; 1994 Sep; 87 Spec No 3():63-7. PubMed ID: 7786126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newer developments in the management of atrial fibrillation.
    Nattel S
    Am Heart J; 1995 Nov; 130(5):1094-106. PubMed ID: 7484742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-pharmacological treatments for atrial fibrillation. A critical perspective on the status quo.
    Murgatroyd FD; Leenhardt A
    Arch Mal Coeur Vaiss; 2000 Apr; 93(3 Spec No):7-16. PubMed ID: 10816796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The place of hybrid therapies with drugs to supplement nonpharmacological therapies in atrial fibrillation.
    Govindan M; Catanchin A; Camm AJ
    J Cardiovasc Pharmacol; 2008 Sep; 52(3):210-21. PubMed ID: 18806601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrial fibrillation and atrial flutter.
    Geraets DR; Kienzle MG
    Clin Pharm; 1993 Oct; 12(10):721-35; quiz 783-4. PubMed ID: 7903069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How to manage atrial fibrillation: an update on recent clinical trials.
    Carlson MD
    Cardiol Rev; 2001; 9(2):60-9. PubMed ID: 11209144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.